Bo Stanley
Analyst · Finian O'Shea with Wells Fargo. Your line is open. Please go ahead
Thanks, Josh. I'd like to start by laying on some additional thoughts on the direct lending environment, and then more specifically, how it relates to the positioning of our portfolio in a way we're thinking about current opportunities in the market. 2022 was a year that underscored the value proposition of private credit for borrowers. New issued leverage loan volume reached a 12-year low and was down 63% from 2021 as public credit markets were largely unavailable. As a result, private credit providers stepped in as a main source of financing solutions, given the ability to provide speed and certainty of execution despite instability in the broader markets. One of the main themes over the last few quarters has been the growing market share of direct lenders and the large syndicated sponsor financings. Direct lenders, with the ability to write sizable checks, are benefiting from the opportunity to participate in larger transactions, which otherwise would have been financed in the broadly syndicated loan market. Notably, these investment opportunities present attractive risk reward dynamics as the deal terms have moved in a more lender-friendly direction, indicated by wider spreads, tighter documents and lower leverage. We believe this shift in the underwriting terms reflects the appropriate compensation to lenders given the uncertain environment we're investing in today. We are well positioned to take advantage of this opportunity in the market, given our ability to invest - alongside affiliated Sixth Street companies. As capital has generally become more constrained, the power of the Sixth Street platform has allowed us to finance larger, more established companies, while remaining selective. We believe this creates a competitive advantage in today's investing environment as the number of direct lenders willing and able to participate in larger transactions is limited. In addition to the strong originations activity supporting this opportunity in the market in Q4, we have a robust pipeline for the first half of 2023, including several large financings that have already been publicly announced. As we have the ability to co-invest with Sixth Street affiliated funds on these transactions, we have flexibility to determine the optimal final hold sizes for our balance sheet. Turning now to our investment activity for the quarter, Q4 was productive, with total commitments of $241 million and total fundings of $212 million across seven new portfolio companies and upsizes to five existing investments. We experienced $282 million of repayments from seven full and three partial investment realizations. The increase in repayment activity was largely driven by idiosyncratic payoffs of our two largest investments by fair value as of 9/30 that we discussed on our last earnings call, violating the front line, which represented 58% of repayments for the quarter. For the full year of 2022, we provided $1.1 billion of commitments and closed $864 million of fundings. Total repayments were $654 million for the year, resulting in net portfolio growth of $210 million. Year-over-year, our portfolio grew by 11%, which reflects our deliberate effort to grow responsibly. We were able to remain selective in the investments that we make, given the size of our capital base, but not require us to be asset gatherers, but rather bottoms up fundamental investors and focus on driving return on capital for our investors. 82% of total commitments this year were sponsored transactions within our specialized sector sub-teams. We continue to execute on our software and business services themes, where we believe we have a competitive advantage and where the underlying companies have attractive revenue characteristics, high-quality customer bases and robust business models. At December 31, our top industry exposure by fair value was to business services at 14.4%. We'd like to take a moment to provide an update on one of our retail ABL investments that has recently been in the press, Bed Bath & Beyond. As mentioned during our Q3, 2022 earnings call, we had aged a FILO term loan commitment in September of 2022 to support the operational turnaround by the company and provide additional liquidity. As a result of this transaction, we hold a $55 million paramount commitment as of 12/31 of the FILO term loan, which represents less than 2% of our total assets as of year-end. On February 6, the company announced it was raising up to $1.025 billion of new equity capital through a public offering. This offering allows the company to avoid bankruptcy found in the near term, which is a positive for all the company's stakeholders, including employees. Along with the capital raise, Sixth Street made an additional investment in a more senior position in the capital structure. Our position, which is already underwritten to liquidation value, is improved as a result of the new capital raise and our more senior position in the capital structure. Obviously, this remains an ongoing situation that at this moment, we feel good about the security. Our retail ABL capabilities have been a distinguishing feature of our investment strategy since we began the company back in 2011. We have executed over 25 transactions and invested over $1 billion of capital through TSLX. On these investments, we have taken 9 through the bankruptcy process without any losses. From a performance perspective, gross unlevered return on fully realized retail ABL investments is 20.8% as of 12/31. We have a core competency in managing these types of investments, and we'll look to continue to execute on this strategy through the same playbook we established years ago. Moving on to the repayment side, one realization that we'd like to highlight is our investment in TherapeuticsMD, which demonstrates the positive impact of proactive asset management for our shareholders. Since our initial investment in 2019, the company faced multiple challenges, including impacts from COVID-19, resulting in underperformance relative to expectations. As the situation evolves, Sixth Street worked with the company as advisers toward a path asset, including multiple amendments and a large partial paydown prior to our exit. In December 2022, Sixth Street's debt was fully repaid when the company licensed full commercial rights of its products. TXMD will continue to be a public company receiving milestone payments and 20 years of royalties on sales. Through active portfolio management and extensive experience in the healthcare space, TSLX generated approximately 15.5% IRR and 1.4x MOM on the investment with a beneficial outcome for both parties. From a portfolio yield perspective, our weighted average yield on debt and income-producing securities at amortized cost increased to 13.4% from 12.2% quarter-over-quarter. The increase primarily reflects a rise in the weighted average reference rate reset of 115 basis points over the quarter. The weighted average yield at amortized cost on new investments, including upsizes for Q4, was 12.6% compared to a yield of 11.9% on exited investments. Looking at the year-over-year trends, our weighted average yield on debt and income producing securities at amortized cost is up about 320 basis points from a year ago. The significant increase in our yields in 2022 illustrates a, positive asset sensitivity for our business from increased base rates beyond our floors in addition to our selective origination approach across themes and sectors. Moving on to the portfolio composition and credit stats across our core borrowers for whom these metrics are relevant. We continue to have conservative weighted average attach and detach points of 0.9 times and 4.5 times respectively. And weighted average interest coverage decreased from 2.6x to 2.2x. The decrease in interest coverage is in line with our expectations from the impact of rising rates on the cost of funds for our borrowers. Our interest coverage metric assumes we apply reference rates as at the end of the year to the run rate borrower EBITDA, we believe this is a better representation of our position of our borrowers as opposed to a look back metric, such as LTM. One additional nuance, we'd like to highlight on interest coverage relates to the positioning of our portfolio towards software and business services. These businesses generally see more limited fixed charge requirements, such as capital expenditures. Other more capital-intensive industries experienced higher fixed charges in addition to financing costs, meaning interest coverage metrics likely understate fixed obligations of those businesses. As of Q4, 2022, the weighted average revenue and EBITDA of our core portfolio companies was $152 million and $46 million, respectively, representing an increase in both metrics from Q3. Finally, the performance rating of our portfolio continues to be strong, with a weighted average rating of 1.12 on a scale of one to five, with one being the strongest, representing no change from last quarter's ratings. We continue to have minimal non-accruals with only one portfolio company on non-accrual representing less than 0.01% of the portfolio at fair value and no new names added to non-accrual during Q4. With that, I'd like to turn it over to Ian to cover our financial performance in more detail.